From: IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma
Tumor
Antibodies
Sensitivity (%)
Specificity(%)
PPV (%)
NPV (%)
EST
IFITM1
86.7
81.8
81.3
87.1
CD10
63.3
78.8
73.1
70.3
CL
h-caldesmon
87.9
93.3
93.5
87.5
SMA
100.0
60.0
73.3